NINGBO DAVID MEDICAL DEVICE CO., LTD. Ningbo David Medical Device Co., Ltd. Stock
Equities
300314
CNE100001DD1
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.06 CNY | +1.28% |
|
-1.25% | -26.95% |
| Sales 2024 * | 971M 134M | Sales 2025 * | 1.29B 179M | Capitalization | 3.19B 440M |
|---|---|---|---|---|---|
| Net income 2024 * | 276M 38.13M | Net income 2025 * | 363M 50.15M | EV / Sales 2024 * | 3.28 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.46 x |
| P/E ratio 2024 * |
11.5
x | P/E ratio 2025 * |
8.78
x | Employees | 774 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 23.67% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.28% | ||
| 1 week | -1.25% | ||
| Current month | -1.07% | ||
| 1 month | -7.83% | ||
| 3 months | -23.93% | ||
| 6 months | -21.95% | ||
| Current year | -26.95% |
1 week
10.81
12.10
1 month
10.8112.47
Current year
8.2315.65
1 year
8.2322.63
3 years
8.2322.63
5 years
7.6427.67
10 years
7.1458.85
| Managers | Title | Age | Since |
|---|---|---|---|
Zai Hong Chen
CEO | Chief Executive Officer | 55 | 10-08-11 |
Ze Dong Li
DFI | Director of Finance/CFO | 50 | 96-02-29 |
Ping Liu
BRD | Director/Board Member | 42 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ze Dong Li
DFI | Director of Finance/CFO | 50 | 96-02-29 |
Zai Hong Chen
CEO | Chief Executive Officer | 55 | 10-08-11 |
Zai Wei Chen
BRD | Director/Board Member | 52 | 92-09-17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 11.06 | +1.28% | 9,925,290 |
| 24-04-12 | 10.92 | -0.91% | 2,397,803 |
| 24-04-11 | 11.02 | -1.08% | 3,680,500 |
| 24-04-10 | 11.14 | -2.96% | 2,873,900 |
| 24-04-09 | 11.48 | +2.50% | 3,156,400 |
End-of-day quote Shenzhen S.E., April 14, 2024
More quotes
Ningbo David Medical Device Co.,Ltd. is a China-based manufacturer of baby care equipment. The Company's main products include infant incubators, infant radiant warmers and neonatal jaundice treatment equipment. The Company's products are mainly used in the first aid and nursing care of premature infants, low birth weight infants, infants with diseases and other neonates. The Company distributes its products in domestic market and to overseas markets.
Calendar
2024-04-19
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
11.06
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -26.95% | 440M | |
| -1.07% | 189B | |
| -2.61% | 107B | |
| -3.74% | 67.81B | |
| +8.44% | 51.87B | |
| +14.04% | 46.67B | |
| -0.77% | 38.68B | |
| +7.58% | 27.73B | |
| +2.52% | 26.6B | |
| +4.89% | 26.34B |
- Stock Market
- Equities
- 300314 Stock
